Global robotic medical imaging market size is estimated to be valued at US$ 10.0 Bn in 2023 and is expected to reach US$ 24.9 Bn by 2030, exhibiting a compound annual growth rate (CAGR) of 13.8% from 2023 to 2030. Robotic medical imaging amalgamates cutting-edge robotic technology with various imaging modalities like X-ray, Magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound within the realm of healthcare. Its primary objective is to augment precision, accuracy, and efficacy in imaging procedures and analyses. By integrating robotics, this field revolutionizes diagnostic capabilities and minimally invasive interventions. These systems assist surgeons in navigating intricate anatomical structures during surgeries while facilitating less invasive procedures, thus subsequently reducing patient discomfort and expediting recovery. Moreover, robotic medical imaging enables radiologists to obtain and interpret images with higher precision, thereby leading to more accurate diagnoses and better patient outcomes. Technological advancements continue to refine these systems by integrating artificial intelligence (AI), by enhancing real-time imaging capabilities, and streamlining automated analysis of medical images. Despite these advancements, challenges persist, including initial setup costs and the necessity for specialized training, but the potential for improved patient care remains substantial.

Analyst’s View on Global Robotic Medical Imaging Market-

The global robotic medical imaging market has significant growth potential over the next decade. The use of robotics in medical imaging is becoming more widespread as it allows for minimally invasive procedures without compromising on image quality or precision. This reduces recovery time for patients as well as health costs. However, factors such as the high initial investment required for robotic systems and maintenance costs can restrain market growth. Asia Pacific is expected to be the fastest growing regional market due to rising healthcare expenditure and increasing patient population. Within the region, countries like China and India are projected to offer lucrative opportunities. North America will continue to dominate the global market supported by developed healthcare infrastructure and rising adoption of innovative technologies. Europe is also a major robotic medical imaging market but regulatory hurdles may slow the pace of growth. Key players should focus on developing affordable robotic platforms tailored for emerging economies. Partnerships with local OEMs can help gain market access while sharing risks. There is a need to optimize systems for telerobotic procedures and remote guidance to make use of expertise across borders. This can revolutionize care in underserved regions. Cloud-based imaging solutions and big data analytics also offer opportunities to improve access, diagnosis and treatment outcomes.  

Global Robotic Medical Imaging Market Drivers:

• Increasing technological advancements: Continuous technological innovations drive the global robotic medical imaging market. Advancements such as AI integration, enhanced imaging modalities, and improved robotic systems have significantly augmented precision and efficacy in medical imaging. These developments offer higher-resolution images, real-time data analysis, and increased automation, thus attracting both healthcare providers and patients by promising more accurate diagnoses and minimally invasive treatments. Moreover, Sysmex Corporation, one of the global leaders in invitro diagnostics, launched  hinotori surgical robot system, a surgical robot unit, and the High frequency series instrument, a reusable active endotherapy device. On December 4, 2020, Sysmex, a global general distributor of Hinotori, will introduce this surgical robot system for use in medical facilities in Japan, beginning with urology departments.
• Increasing prevalence of chronic diseases: Increasing prevalence of chronic diseases like cancer and cardiovascular conditions has driven  the demand for precise diagnostics and targeted treatments. Robotic medical imaging provides a means to accurately visualize affected areas, thus enabling early detection and precise interventions. This factor has significantly contributed to the market's growth as it addresses the need for better disease management and personalized therapies. Furthurmore, increasing prevalence of chronic diseases is expected to drive the market growth over the forecast period. For instance, in July 2022, Centers for Disease Control and Prevention, according to the data published by a national public health agency of the U.S., six in 10 adults of U.S. have a chronic disease moreover four in 10 adults have two or more chronic diseases.
• Demand for minimally invasive procedures: There is a growing preference for minimally invasive procedures due to reduced post-operative complications, shorter recovery times, and improved patient outcomes. Robotic medical imaging facilitates these procedures by offering enhanced visualization, precise navigation, and guidance during surgeries and interventions, thereby driving its adoption in the medical field. The increased need for minimally invasive procedures is expected to continue driving demand for advanced robotic medical imaging technologies. According to projections by World Health Organization (WHO), the number of cancer cases is expected to rise by over 70% in next 20 years. This is likely to significantly increase the need for minimally invasive cancer treatment procedures which will further increase the adoption of robotic medical imaging systems that assist surgeons to efficiently and precisely conduct such intricate surgical interventions through small incisions rather than traditional open surgeries. The aging global population also means greater demand for orthopedic procedures which can take advantage of robotics to enable minimal invasiveness.

Global Robotic Medical Imaging Market Opportunities:

• Expansion in emerging markets: Emerging economies present significant opportunities for market growth due to increased healthcare expenditure, improving healthcare infrastructure, and a growing patient pool. These regions offer untapped markets where the adoption of robotic medical imaging systems can address the rising healthcare needs and provide advanced diagnostic and treatment options. Adoption in emerging markets is likely to be driven by growing middle class populations seeking quality care. According to the data provided by the World Bank, the number of middle class populations increased from around 375 Mn to over 1 Bn individuals in developing countries between 2000-2021. With such expanding consumer bases that can afford premium services, robotic medical imaging stands to gain significant traction. Diagnostic centers and hospitals targeting these socioeconomic demographics will look to incorporate cutting-edge solutions like robotic X-rays, CTs, ultrasound, and others  to attract patients and stay competitive.
• AI Integration and Data Analytics: Integration of artificial intelligence (AI) and machine learning in robotic medical imaging systems presents vast opportunities. AI-powered analytics enable automated interpretation of medical images, predictive analysis, and personalized patient care. Integration streamlines diagnostic processes, enhances accuracy, and contributes to more efficient and data-driven decision-making in healthcare.  According to projections by the United Nations Department of Economic and Social Affairs, the global population aged 65 and over is expected to more than double from 2018 to 2050. As populations across regions age considerably in the near future, demand will grow for advanced medical solutions tailored to their needs. Robotic technology integrated with AI is uniquely positioned to help fill this care gap by facilitating affordable, accessible healthcare in both clinical and personalized home settings through predictive analytics, precision diagnostics, and automated monitoring of chronic conditions.

Global Robotic Medical Imaging Market Restraints:

• High initial costs: The high initial investment required for acquiring and implementing robotic medical imaging systems poses a significant barrier to the market growth. These systems involve substantial capital expenditure for purchase, installation, and maintenance, thus limiting their accessibility, particularly in resource-constrained healthcare settings. Moreover, provided  their high costs, healthcare providers are often reluctant to be early adopters of new robotic imaging technologies unless there is clear clinical evidence, establishing a strong return on investment. In 2020, according to the United Nations report, in low-income countries, the average government expenditure on healthcare per capita is only around US$86. This restricts their ability to modernize diagnostic imaging facilities with expensive robotic options when basic healthcare needs are yet to be met adequately. Unless initial costs come down significantly, this will continue posing a barrier to the global market's expansion into price-sensitive regions.
• Regulatory challenges and safety concerns: Stringent regulatory approvals and compliance requirements in different regions can impede market expansion. Ensuring the safety and efficacy of robotic medical imaging systems remains a concern, by influencing adoption rates and hindering widespread implementation in healthcare facilities. Any defects or technical glitches, once the products are in clinical use, can damage the reputation of manufacturers, thus leading to lawsuits and product recalls. This reputational and financial risk makes companies extra cautious before introducing new functionalities or upgrading existing robotic technologies. According to data published by the World Health Organization (WHO), between 2010-2021, 21 medical device recalls were reported globally due to safety issues in robotic imaging systems like surgical robots. This generated apprehensions among hospitals, surgeons, and patients regarding the dependability of existing medical robot solutions.

Counterbalance: The key market players need to be extra vigilant in carrying out the strict regulatory approval and the necessary compliances. This is, in order to ensure safety and efficacy of the robotic medical imaging systems at the time of introducing new functionalities, to avoid product recalls.

• Telemedicine and remote imaging: Integration of robotic medical imaging with telemedicine has gained momentum, thus enabling remote access to imaging data and consultations. This trend facilitates remote diagnostics, expert consultations, and real-time monitoring, especially in underserved or remote areas, thereby improving healthcare accessibility and patient outcomes. For example, the U.S. Bureau of Labor Statistics reported, that in 2021, 32% of rural Americans did not have reliable broadband internet access, which impacts their ability to utilize telehealth solutions. However, robotic imaging systems with integrated telemedicine functions can still perform scans remotely and send the images to radiologists for interpretation through existing connectivity methods. As a result of these benefits, experts anticipate strong growth in the tele-robotic medical imaging segment in the near future. According to projections by the Healthcare Information and Management Systems Society, the U.S. telehealth market is expected to grow over 40% annually between 2018-2025. A large portion of this growth will be driven by robotic solutions that support remote care delivery through imaging. Leading manufacturers are heavily investing in technologies that combine robotic, AI, and telemedicine capabilities. This convergence of innovations will change how healthcare is accessed globally, supporting both patients and providers through digital connected care.
• Personalized medicine and precision imaging: There is a growing trend toward personalized medicine, where robotic medical imaging plays a crucial role. Tailoring treatments based on individual patient data, including genetic information and precise imaging diagnostics, is becoming increasingly prevalent. This trend emphasizes the importance of customizing healthcare solutions for better patient outcomes. According to the data provided by  the American Association for Clinical Chemistry, between 2020-2022, over 80% of U.S. hospitals adopted new precision imaging machines to support their personalized healthcare programs. Simultaneously, prestigious cancer institutes like MD Anderson Cancer Center have reported correlations between acquiring cutting-edge whole-body robotic Positron emission tomography (PET)/ Computed Tomography (CT) scanners and improved survival rates for several complex cancer cases that is benefited from customized treatments that are planned by using advanced images. This clearly displays how precision imaging is translating to better patient outcomes and driving expanded uptake of new robotic technology.

Global Robotic Medical Imaging Market Regional Insights:

• North America is expected to be the largest market for robotic medical imaging market during the forecast period, accounting for over 38% of the market share in 2022. The market growth in North America is due to the high adoption of advanced robotic surgical systems, increasing number of product approvals, and rising patient preference for minimally invasive surgeries in the region.
• The Europe market is expected to be the second-largest market for robotic medical imaging market, accounting for over 27% of the market share in 2022. The market growth of the market in Europe is due to the rising cases of chronic disorders, presence of major companies, and increasing funding for medical robotics research in the region.
• The Asia Pacific market is expected to be the fastest-growing market for robotic medical imaging market, with a CAGR of over 19% during the forecast period. The market growth in Asia Pacific is due to the improving healthcare infrastructure, rising disposable incomes, and growing awareness about advanced surgical treatments in the region.

Figure 1. Global Robotic Medical Imaging Market Share (%), by Region, 2023

Intuitive Surgical, Inc., Accuray Incorporated, Zimmer Biomet Holdings, Inc., Siemens Healthineers AG, Medtronic plc., GE Healthcare, Stryker Corporation, Titan Medical Inc., Hocoma AG, Mazor Robotics and Medrobotics Corporation

New product launches and Approvals

• On October 9, 2023, Body Vision Medical, a medical technology manufacturer announced the latest software update for its revolutionary LungVision navigation and real-time imaging platform which is introducing Body Vision's latest AI tomography imaging algorithm, a streamlined workflow when used during robotic-assisted bronchoscopy (RAB), reduces overall radiation exposure to medical staff and the patient during lung nodule biopsy procedures. The latest software also streamlines the LungVision workflow when used in conjunction with robotic bronchoscopy platforms like the Ethicon Monarch and Ion by Intuitive Surgical.
• On September 13, 2023, Insight Medbotics, a medical device company announced a successful 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the IGAR system, a Magnetic Resonance Imaging (MRI) compatible robot used for breast biopsy indications.
• On March 2, 2023, Noah Medical, a Medical equipment manufacturer announced U.S. FDA clearance of the Galaxy System and its accessories which are intended to provide bronchoscopic visualization of and access to patient airways for diagnostic and therapeutic procedures.
• On May 3, 2023, Quantum Surgical, a medical robotics company received an extension of authorization from the U.S, Food and Drug Administration (FDA) for Epione robot, which is dedicated to the cure treatment of cancers and allows physicians to treat tumors that are particularly difficult to reach, due to their size or their location, at an early stage, in a simple and effective way.

Acquisition, Collaboration and Partnerships:

• On April 20, 2023, Alphatec announced that it acquired all assets related to the REMI robotic navigation system, a robotic-enabled minimally invasive system integrates navigation and robotics into spine procedures from Fusion Robotics.
• On June 22, 2023, Intrinsic, an alphabet company and Siemens collaborated to accelerate the integration of AI-based robotics and automation technology.
• In November 2022, CMR Surgical (CMR), announced a collaboration agreement with Ethicon, a Johnson & Johnson MedTech company to expand choice across surgical robotics and advanced laparoscopic instruments. CMR’s Versius system represents the next generation of collaborative surgical robotics as well as an industry leading clinical registry and comprehensive digital ecosystem that are complementary to Ethicon’s surgical technologies.

By Product Type:

• • MRI Systems
  • CT Scanners
  • X-ray Systems
  • Ultrasound Systems
  • Others (Endoscopy Robots, Nuclear Imaging Robots, etc.)

By Application:

• • General Surgery
  • Urology
  • Gynecology
  • Orthopedics
  • Neurosurgery
  • Others (Oncology, Gastrointestinal, etc.)

By End User:

• • Hospitals
  • Diagnostic Centers/Clinics
  • Ambulatory Surgical Centers
  • Research Institutes
  • Others (Specialty Clinics, etc.)

By Region:

• • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa